Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new analysis also found a correlation between higher adherence to the daily drug regimen and greater bone density loss.
The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.
The much-celebrated HIV prevention pill is failing to reach those at highest risk for the virus: Black men who have sex with men.
Celebrating 20 years of effective HIV treatment
What does the future hold for new pre-exposure prophylaxis (PrEP) against HIV, including long-acting injectables and less toxic drugs?
Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) protects transgender women against HIV if they take it consistently.
The PROUD study, which found that PREP reduced HIV risk by 86 percent in English high-risk gay and bi men, has been published in the Lancet.
People with hepatitis B can safely take Truvada as PrEP, as it does not lead to liver inflammation “flares” or other health problems whe...
AIDS Healthcare Foundation published an ad criticizing pre-exposure prophylaxis (PrEP) in various gay publications around the country.
Canadian research suggests that rolling out Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) to prevent HIV would save mon...
Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) causes a small decrease in bone mineral density during the first six mont...
A group of British gay and bi men given Truvada as PrEP had an overall 86 percent lower risk of HIV as a consequence.
A study of “on demand” PrEP abruptly canceled its placebo arm when the protocol showed high efficacy in preventing HIV.
CDC researchers have estimated how well condoms and PrEP prevent HIV in gay and bisexual men. How much faith can be placed in these figures?
For first time, a study has shown, although rare, resistance to Truvada can develop if someone contracts HIV while taking the drug as PrEP.
The use of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) is on the rise in the United States, in particular among men
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.